A Study of CTX-4430 in Patients with Cystic Fibrosis
Research type
Research Study
Full title
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CTX-4430 when Administered Orally to Cystic Fibrosis Patients for Fifteen Days
IRAS ID
136015
Contact name
J. Stuart Elborn
Contact email
Sponsor organisation
Celtaxsys, Inc
Eudract number
2013-001593-25
REC name
HSC REC A
REC reference
13/NI/0106
Date of REC Opinion
22 Aug 2013
REC opinion
Further Information Favourable Opinion